Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Akane Kawamura.

Newcastle AuthorsTitleYearFull text
Professor Akane Kawamura
Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease2024
Dr Roman Belle
Dr Hilal Sarac
Dr Grace Roper
Professor Akane Kawamura
Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate2024
Tom Smith
Professor Akane Kawamura
Identification and engineering of potent cyclic peptides with selective or promiscuous binding through biochemical profiling and bioinformatic data analysis2024
Klemensas Simelis
Dr Hilal Sarac
Dr Tom McAllister
Dr Roman Belle
Professor Akane Kawamura
et al.
Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling2024
Dr Oliver Coleman
Dr Tom McAllister
Siddique Amin
Professor Akane Kawamura
Cyclic peptides target the aromatic cage of a PHD-finger reader domain to modulate epigenetic protein function2023
Catherine Salvini
Benoit Darlot
Jack Davison
Dr Mathew Martin
Dr Susan Tudhope
et al.
Fragment expansion with NUDELs – poised DNA-encoded libraries2023
Professor Akane Kawamura
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease2023
Dr Joanna Bonnici
Professor Akane Kawamura
The catalytic domains of all human KDM5 JmjC demethylases catalyse N-methyl arginine demethylation2023
Dr Oliver Coleman
Professor Akane Kawamura
An integrated platform approach enables discovery of potent, selective and ligand-competitive cyclic peptides targeting the GIP receptor2022
Professor Akane Kawamura
Increasing Diversity in Admissions to Postgraduate Study2022
Dr Roman Belle
Dr Vinod Kumar
Professor Akane Kawamura
Reading and erasing of the phosphonium analogue of trimethyllysine by epigenetic proteins2022
Toni Pringle
Dr Oliver Coleman
Professor Akane Kawamura
Dr James Knight
The influence of degree of labelling upon cellular internalisation of antibody-cell penetrating peptide conjugates2022
Professor Akane Kawamura
Hypoxia and hypoxia mimetics differentially modulate histone post-translational modifications2021
Dr Tom McAllister
Professor Akane Kawamura
Structural diversity in de novo cyclic peptide ligands from genetically encoded library technologies2021
Professor Akane Kawamura
Chemical compounds targeting DNA methylation and hydroxymethylation2020
Professor Akane Kawamura
Cyclic Peptides as Chemical Probes2020
Professor Akane Kawamura
Engineered anti-inflammatory peptides inspired by mapping an evasin-chemokine interaction2020
Professor Akane Kawamura
Epigenetics equals chemical biology2020
Professor Akane Kawamura
Inhibitors of JmjC-containing Histone Demethylases: Structural Perspective2020
Professor Akane Kawamura
Light-driven post-translational installation of reactive protein side chains2020
Professor Akane Kawamura
Metampicillin is a Cyclic Aminal Produced by Reaction of Ampicillin With Formaldehyde2020
Dr Hilal Sarac
Professor Akane Kawamura
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer2020
Dr Tom McAllister
Professor Akane Kawamura
Use of Cyclic Peptides to Induce Crystallization – Case Study with Prolyl Hydroxylase Domain 22020
Professor Akane Kawamura
Using evasins to target the chemokine network in inflammation2020
Professor Akane Kawamura
A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins2019
Professor Akane Kawamura
Corrigendum to “Structure-activity studies of a macrocyclic peptide inhibitor of histone lysine demethylase 4A” (Bioorganic & Medicinal Chemistry (2018) 26(6) (1225–1231), (S0968089617318497) (10.1016/j.bmc.2018.01.013))2019
Professor Akane Kawamura
Design, Synthesis and Characterization of Covalent KDM5 Inhibitors2019
Professor Akane Kawamura
Formaldehyde quantification using ampicillin is not selective2019
Professor Akane Kawamura
JmjC-domain-Containing Histone Demethylases2019
Professor Akane Kawamura
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases2019
Dr Tom McAllister
Professor Akane Kawamura
2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 22018
Professor Akane Kawamura
Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets2018
Professor Akane Kawamura
Human histone demethylase KDM6B can catalyse sequential oxidations2018
Professor Akane Kawamura
In vitro enzyme assays for jmjC-domain-containing lysine histone demethylases (JmjC-KDMs)2018
Professor Akane Kawamura
Inhibitors of both the N-methyl lysyl- and arginyl-demethylase activities of the JmjC oxygenases2018
Professor Akane Kawamura
Investigations on small molecule inhibitors targeting the histone H3K4 tri-methyllysine binding PHD-finger of JmjC histone demethylases2018
Professor Akane Kawamura
Lysine-241 Has a Role in Coupling 2OG Turnover with Substrate Oxidation During KDM4-Catalysed Histone Demethylation2018
Professor Akane Kawamura
Mechanistic and structural studies of KDM-catalysed demethylation of histone 1 isotype 4 at lysine 262018
Dr Tom McAllister
Professor Akane Kawamura
Non-competitive cyclic peptides for targeting enzyme-substrate complexes2018
Professor Akane Kawamura
Structure-activity studies of a macrocyclic peptide inhibitor of histone lysine demethylase 4A2018
Professor Akane Kawamura
Synthesis and Biological Evaluation of Tripartin, a Putative KDM4 Natural Product Inhibitor, and 1-Dichloromethylinden-1-ol Analogues2018
Professor Akane Kawamura
The N-terminal domain of a tick evasin is critical for chemokine binding and neutralization and confers specific binding activity to other evasins2018
Professor Akane Kawamura
Thioether Macrocyclic Peptides Selected against TET1 Compact Catalytic Domain Inhibit TET1 Catalytic Activity2018
Professor Akane Kawamura
Assessing histone demethylase inhibitors in cells: Lessons learned2017
Professor Akane Kawamura
Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/72017
Professor Akane Kawamura
Highly selective inhibition of histone demethylases by de novo macrocyclic peptides2017
Professor Akane Kawamura
Investigating d-lysine stereochemistry for epigenetic methylation, demethylation and recognition2017
Professor Akane Kawamura
KDM3A coordinates actin dynamics with intraflagellar transport to regulate cilia stability2017
Dr Tom McAllister
Professor Akane Kawamura
KDM4A regulates HIF-1 levels through H3K9me32017
Professor Akane Kawamura
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials2017
Professor Akane Kawamura
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells2017
Professor Akane Kawamura
Selective recognition of the di/trimethylammonium motif by an artificial carboxycalixarene receptor2017
Professor Akane Kawamura
Studies on the Interaction of the Histone Demethylase KDM5B with Tricarboxylic Acid Cycle Intermediates2017
Professor Akane Kawamura
The Activity of JmjC Histone Lysine Demethylase KDM4A is Highly Sensitive to Oxygen Concentrations2017
Professor Akane Kawamura
Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities2017
Professor Akane Kawamura
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors2016
Professor Akane Kawamura
Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases2016
Dr Tom McAllister
Professor Akane Kawamura
Recent Progress in Histone Demethylase Inhibitors2016
Professor Akane Kawamura
Tetracyanoresorcin[4]arene selectively recognises trimethyllysine and inhibits its enzyme-catalysed demethylation2016
Professor Akane Kawamura
Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases2015
Professor Akane Kawamura
Epigenetic regulation by histone demethylases in hypoxia2015
Professor Akane Kawamura
Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain2015
Professor Akane Kawamura
A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX12014
Professor Akane Kawamura
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding2014
Professor Akane Kawamura
Modulating carnitine levels by targeting its biosynthesis-selective inhibition of γ-butyrobetaine hydroxylase2014
Professor Akane Kawamura
Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases2014
Professor Akane Kawamura
Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor2014
Professor Akane Kawamura
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities2014
Professor Akane Kawamura
Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition2014
Professor Akane Kawamura
Studies on the catalytic domains of multiple JmjC oxygenases using peptide substrates2014
Professor Akane Kawamura
Targeting histone lysine demethylases - Progress, challenges, and the future2014
Dr Paul Brennan
Professor Akane Kawamura
5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation2013
Professor Akane Kawamura
Identification of the KDM2/7 histone lysine demethylase subfamily inhibitor and its antiproliferative activity2013
Professor Akane Kawamura
Is JmjC Oxygenase Catalysis Limited to Demethylation?2013